Results for tag: "Hyqvia"

Hyqvia is a brand of immune disorder drugs used to treat primary immunodeficiency diseases (PIDDs). It is a subcutaneous immunoglobulin (SCIG) therapy, which is a type of immunotherapy that helps to replace the antibodies that are missing in people with PIDDs. Hyqvia is a combination of two proteins, human immunoglobulin G (IgG) and recombinant human hyaluronidase, which helps to increase the absorption of IgG into the body. This helps to improve the body's ability to fight off infections and other diseases. Hyqvia is administered through a subcutaneous injection, which is a less invasive method than intravenous infusions. The Hyqvia market is a growing sector of the immune disorder drugs industry. It is a relatively new form of therapy, but is becoming increasingly popular due to its convenience and effectiveness. Hyqvia is used to treat a variety of PIDDs, including common variable immunodeficiency, X-linked agammaglobulinemia, and chronic granulomatous disease. Some companies in the Hyqvia market include Baxalta, CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more